Anticancer Agent – Targeting a novel oncogene in the treatment of cancer

The trim71 gene encodes for the human multi-domain protein TRIM71 which is required for the development of several vertebrate and invertebrate organisms. It plays an important role in the regulation of cell differentiation and cell-matrix interactions.

The present invention shows the significant role of TRIM71 in the proliferation of cancer cells. TRIM71 is scarcely expressed in healthy adult tissues, but strongly up-regulated in human cancers, especially in cancers of the ovary, the lung and the kidney. It is involved in the control of cellular interactions and cellular differentiation within the tumour microenvironment and obviously functions as an oncogene. TRIM71 might therefore be a target to reduce the progression of human neoplasia.

Further Information: PDF

PROvendis GmbH
Phone: +49 (0)208/94105 10

Contact
Dipl.-Ing. Alfred Schillert

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Recovering phosphorus from sewage sludge ash

Chemical and heat treatment of sewage sludge can recover phosphorus in a process that could help address the problem of diminishing supplies of phosphorus ores. Valuable supplies of phosphorus could…

Efficient, sustainable and cost-effective hybrid energy storage system for modern power grids

EU project HyFlow: Over three years of research, the consortium of the EU project HyFlow has successfully developed a highly efficient, sustainable, and cost-effective hybrid energy storage system (HESS) that…

After 25 years, researchers uncover genetic cause of rare neurological disease

Some families call it a trial of faith. Others just call it a curse. The progressive neurological disease known as spinocerebellar ataxia 4 (SCA4) is a rare condition, but its…

Partners & Sponsors